In addition to the potential for reducing adiposity, we believe that the improved insulin sensitivity in Mstn−/−, muscle-DN, and constitutively active Akt1 mice suggests that altering metabolism by increasing muscle mass might be a promising strategy for treating diabetes and the metabolic syndrome. The gene discussed is AKT1; the disease is diabetes mellitus.